# Study on Neostigmine Acupoint Injection at Zusanli(ST36) for Treating Mechanical Ventilation-Associated Gastrointestinal Dysfunction

> **NCT07692282** · NA · NOT_YET_RECRUITING · sponsor: **Southeast University, China** · enrollment: 90 (estimated)

## Conditions studied

- Gastrointestinal Dysfunction

## Interventions

- **DRUG:** Neostigmine Acupoint Injection
- **DRUG:** Neostigmine subcutaneous injection
- **DRUG:** Acupoint normal saline injection

## Key facts

- **NCT ID:** NCT07692282
- **Lead sponsor:** Southeast University, China
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2028-02
- **Final completion:** 2028-02
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07692282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07692282, "Study on Neostigmine Acupoint Injection at Zusanli(ST36) for Treating Mechanical Ventilation-Associated Gastrointestinal Dysfunction". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07692282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*